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Background: Mutations in CCBE1 have been found to be responsible for a subset of families with autosomal
recessive Hennekam syndrome. Hennekam syndrome is defined as the combination of generalized lymphatic
dysplasia (ie. lymphedema and lymphangiectasia), variable intellectual disability and characteristic dysmorphic
features. The patient we describe here has a lymphatic dysplasia without intellectual disability or dysmorphism
caused by mutation in CCBE1, highlighting the phenotypic variability that can be seen with abnormalities in this
gene.
Case presentation: Our patient is a 5 week old child of Pakistani descent who presented to our center with
generalized edema, ascites, and hypoalbuminemia. She was diagnosed with a protein losing enteropathy secondary
to segmental primary intestinal lymphangiectasia. As the generalized edema resolved, it became clear that she had
mild persistent lymphedema in her hands and feet. No other abnormalities were noted on examination and
development was unremarkable at 27 months of age. Given the suspected genetic etiology and the consanguinity
in the family, we used a combination of SNP genotyping and exome sequencing to identify the underlying cause
of her disease. We identified several large stretches of homozygosity in the patient that allowed us to sort the
variants found in the patient’s exome to identify p.C98W in CCBE1 as the likely pathogenic variant.
Conclusions: CCBE1 mutation analysis should be considered in all patients with unexplained lymphatic dysplasia
even without the other features of classic Hennekam syndrome.
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Hennekam syndrome (OMIM#235510) is a disorder of
lymphatic development that includes lymphedema, lym-
phangiectasia, characteristic dysmorphism and cognitive
impairment [1]. The dysmorphic features include a flat
nasal bridge, hypertelorism, and small mouth. Approxi-
mately 25% of patients who have Hennekam syndrome
were found to have autosomal recessive mutations in
CCBE1 [2] and a further 20% of patients have mutations* Correspondence: pfrosk@hsc.mb.ca
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creativecommons.org/publicdomain/zero/1.0/in FAT4 [3]. CCBE1 is clearly important for lymphatic
development based on animal models [4,5] however the
connection of FAT4 to lymphatic development is still
obscure.
Our understanding of the phenotype associated with
CCBE1 mutation has evolved over time. The original re-
port noted that patients with Hennekam syndrome dem-
onstrate significant variability in the degree of cognitive
impairment (ranging from normal to moderate impair-
ment) [2]. However, all of the original reported patients
had the severe lymphatic abnormalities and characteris-
tic dysmorphic features. A recent report compared indi-
viduals with a clinical diagnosis of Hennekam Syndrome
with and without mutations in CCBE1 [6]. This articleicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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difficulties although all had intestinal lymphangiectasia,
appendicular lymphedema and dysmorphic features.
Other reports of patients with CCBE1 mutations have
classified a few families as having “generalized lymphatic
dysplasia”. One family included three affected individ-
uals, all of whom had hydrops fetalis, and two of whom
had died in early life [7]. The proband of the latter fam-
ily, at the age of 6 years, had normal development but
most of the other features were consistent with Henne-
kam syndrome (massive lymphedema, gut lymphangiec-
tasia, and dysmorphic features consistent with in utero
edema). The second family had an affected sib pair with
normal development, gut lymphangiectasia, subtle dys-
morphisms, and moderate lymphedema [8]. There is one
report that suggests CCBE1 may also be a cause of
lymphedema-cholestasis syndrome (OMIM#214900), al-
though it isn’t clear if this was the coincidental finding
of Hennekam along with cholestasis or whether CCBE1
mutation was the underlying cause of the cholestasis as
well, perhaps secondary to a lymphatic effect [9].
Given that most of the consistent features of Henne-
kam syndrome are felt to be secondary to disordered
lymphatic development in utero [1], it seems reasonable
to conclude that these patients all represent the same
underlying pathogenetic mechanism, just with varying
severity. The patient we present here is likely the mildest
to be reported to date with mutations in CCBE1 which
suggests Hennekam syndrome has an even broader
phenotypic variability than previously thought.
Case report
This female infant was born to a 29 year old G2P1 mother
at term via an emergency C-section due to fetal distress.
During the prenatal period, an echogenic intracardiac
focus and nuchal thickening (6-7 mm) were identified at
21 weeks gestation. The family received genetic counseling
and further investigations were declined. Apgar scores
were 8 at 1 minute and 8 at 5 minutes and the infant fed
well shortly after birth. Postnatal exam showed a healthy
appearing infant with bilateral type B postaxial polydactyly
of the hands (postminimus). She did well in this immedi-
ate post-natal period and, after removal of the polydactyly,
was discharged from the hospital. At home she was fed
breast milk but, even with adequate volumes grew poorly.
She was admitted to our hospital at 26 days of age with
severe failure to thrive and a history of diarrhea and occa-
sional emesis. Serum albumin levels during this admission
ranged from 13 – 17 g/L (normal range 32 – 48 g/L).
When she was switched to a hypo-allergenic formula, she
started gaining weight and was discharged with a
provisional diagnosis of cow’s milk protein allergy. She
presented again at 51 days of age with significant asci-
tes, generalized edema and severe hypoalbuminemiawith a serum albumin level of 10 g/L. The remainder
of her examination was unremarkable. Large volume,
non-bloody diarrhea had continued to be a problem
throughout the time at home despite the change in
formula.
Her investigations included a normal CBC with nor-
mal lymphocytic count, normal liver enzymes, normal
bilirubin, low serum transferrin, low serum immuno-
globulins and normal thyroglobulin. Her stools were
negative for fat globules and reducing substances. How-
ever, 24 hour-stool collection had a markedly elevated
alpha-1-antitrypsin level of 576 mg/g (normal <54 mg/g)
indicative of protein losing enteropathy. Esophagogastro-
duodenoscopy and sigmoidoscopy were performed and
did not reveal any obvious abnormalities. Biopsies taken
at the same time were also unremarkable by both light
and electron microscopy. A small bowel contrast study
showed thickening and nodularity in several segments of
the small bowel suggestive of segmental intestinal lym-
phangiectasia. Treatment during her admission included
multiple albumin infusions and eventually a switch to a
medium chain triglyceride (MCT) containing formula.
She responded very well with resolution of vomiting and
diarrhea. At discharge, the ascites had resolved as had
most of the edema and she was gaining weight appropri-
ately. At her last clinical assessment she was 27 months of
age and her albumin levels were maintained at 25-30 g/L
on a MCT rich-diet. With the resolution of the facial
edema evident in hospital she was non-dysmorphic based
on the assessments of two experienced dysmorphologists
(B.C. and C.R.G) and there was absence of distichiasis.
Her height, weight, and occipitofrontal circumference
were all between the 50th and 75th percentiles. Her hands
and feet continued to be mildly edematous despite control
of her albumin levels. Her development was considered
normal with age appropriate verbal and motor skills and
no social concerns or abnormal behaviors. Her develop-
ment was assessed on the Bayley scales of infant and tod-
dler development, 3rd edition (Bayley III) and showed a
Cognitive Composite at the 25th centile, a Language
Composite at the 34th centile and a Motor Composite at
the 50th centile.
Her family history was significant for consanguinity
with her parents being first cousins of Pakistani descent.
There was an older healthy male sibling. A maternal
aunt had an undiagnosed disorder which included cor-
neal clouding and she died at 13 years of age. Genetic
investigations in our patient were initiated early on in
the course of her hospitalization and included a normal
transferrin isoelectric focusing, normal plasma amino
acids, normal urine organic acids and normal urine mu-
copolysaccharides. Her karyotype was 46,XX and an
array CGH was done which identified an ~100 kb dele-
tion on chromosome 15q11.2 that encompasses exon
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ical region). This was felt to be an incidental finding as
it was inherited from her normal father and there was
no overlap of her symptoms with classic Prader-Willi
syndrome.
An autosomal recessive lymphatic dysplasia was
strongly suspected given the consanguinity. In order to
identify the causative mutation, we used a combination
of SNP genotyping and exome sequencing. The nuclear
family was genotyped using Illumina Human Omni 2.5
SNP arrays at the Centre for Applied Genomics, To-
ronto, Canada. Twenty-seven regions of homozygosity
containing >1000 SNPs were evident in the patient sam-
ple and ranged in size from 0.9-37.5 Mb. Segregation
analysis was used to rule out some of these regions, leav-
ing ~183 Mb of sequence that appeared to be identical
by descent (IBD) but not present in the unaffected
brother. Exome sequencing was performed on the af-
fected patient as described for previous FORGE projects
[10]. Mean Consensus Coding Sequence (CCDS) cover-
age was 132X with 93% of bases covered by at least 20
reads. Approximately 180,000 moderate to high quality
variants were identified in the sample. Using the regions
of IBD and other filters consistent with our genetic
model, we were able to narrow the candidates down to 5
possibilities (Fig. 1a). The most likely candidate, based
on previous functional data, was a homozygous missense
variant in CCBE1 (c.294 T >G, p.C98W [NM_133459]).
This variant segregates in the family with both parents
being carriers (Fig. 1b). This variant is rare (not found
in dbSNP or the NHBLI exome server) and affects a
highly conserved amino acid found within the EGF
calcium-binding domain. Orthologs from 38/39 species,
ranging from placental mammals to fish, show conserva-
tion of this residue suggesting functional importance
(Fig. 1c).
Collagen- and calcium-binding domain 1 (CCBE1) is a
signaling molecule essential for lymphangiogenesis in
humans and model organisms. Initial description of
CCBE1 function came from a zebrafish mutant, full of
fluid (fof ), identified on a forward genetic screen [4].
These fish had an absence of truncal lymphatic vessels,
including the thoracic duct, and developed significant
edema. The cause for this zebrafish mutant was deter-
mined to be a missense mutation within the CCBE1
EGF domain (p.D162E) suggesting this protein was es-
sential for appropriate lymphangiogenesis. Creation of a
knockout mouse allowed further elucidation of the func-
tion of CCBE1 [5]. CCBE1 knockout mice died pre-
natally with progressive edema beginning at E13.5
onward and lacked all detectable lymphatic vessels. The
protein was found to be excreted and bound to the
extracellular matrix, acting as a potentiating factor of
VEGF-C in lymphatic budding and outgrowth.Mutations in the CCBE1 gene have been found in pa-
tients with Hennekam syndrome of varying severity. Our
patient appears to represent the mildest of this pheno-
typic spectrum. Certainly, the mutation identified in her
(p.C98W) is similar to missense mutations that have
been identified in other Hennekam patients (eg. p.C47F,
p.C75S, p.C102S, p.R158C, p.C174R, and p.C174Y) [2,
6]. All of these mutations affect cysteine residues within
the EGF domain and given the disulfide linkages within
EGF domains, it is reasonable to assume all of them will
disrupt the tertiary structure of the domain to a certain
degree. Three of these previously reported mutations
(p.C75S, p.C102S, and p.C174R) were studied further
and had reduced ability to rescue zebrafish ccbe1 knock-
down morphants, confirming their pathogenicity [2].
Further functional work is needed to determine if the
p.C98W allele is the reason for her milder phenotype or
whether there are alternate genetic or environmental
factors at play.
The outstanding issue in this case is the preaxial poly-
dactyly of her hands. No other individuals in the family
have polydactyly (either currently or treated at birth like
our patient). This anomaly has never been seen in
CCBE1-related disease nor has it been associated with
the clinical entity of Hennekam syndrome to our know-
ledge. Postaxial polydactyly has been reported to be associ-
ated with intestinal lymphangiectasia in Urioste syndrome,
however, this clinical entity also includes hepatic failure,
persistence of the Mullerian ducts in males and all re-
ported patients have died within 1 year of age [11–13].
The underlying cause of Urioste syndrome remains un-
known but it does seem unlikely to be associated with mu-
tation in CCBE1 given the lack of any Mullerian
abnormalities or hepatic failure in the known CCBE1 pa-
tients [6]. It is possible that the polydactyly in our patient
is unrelated to the lymphatic disorder. We did review her
molecular data for other variants that could independently
cause polydactyly via a candidate gene approach but we
were unsuccessful. At this point it is unclear whether this
feature is related to her CCBE1 mutation or not.
Conclusions
Hennekam syndrome is clearly a disorder of lymphatic
development. The classic phenotype includes lymphan-
giectasia (particularly of the gut), lymphedema, charac-
teristic dysmorphic features, and intellectual disabilities.
Certainly the lymphangiectasia and lymphedema are dir-
ectly related to lymphatic development. It seems likely
the dysmorphic features (round flat face, flat bridge of
the nose, hypertelorism, and small mouth) are all sec-
ondary to in utero lymphatic perturbations when the fa-
cial structures are being formed. We cannot exclude the
possibility that there is some direct effect on facial mor-
phogenesis from the CCBE1 mutation itself, however,
Fig. 1 Molecular analysis identifying a mutation in CCBE1 as the likely cause of disease. (a) Exome sequencing data from patient IM03. Filter
criteria are as shown. The candidates eliminated on manual review were largely known polymorphisms that were not called appropriately by the
annotation algorithm. Five candidates could not be definitively excluded. The most likely candidate for the disease-causing mutation is in CCBE1
given the known function of the gene and its association with a related phenotype in humans (Hennekam Syndrome). (b) Confirmatory Sanger
sequencing of the CCBE1 variant identified through the exome analysis. The variant is a T > G transversion at position 294 of the coding sequence
(c.294 T > G). This changes codon 98 from a cysteine to a tryptophan (p.C98W). In the above figure, + represents wild type sequence. On the
electropherograms the upper portion represents the actual sequence read and the lower portion represents the expected sequence along with
the translation. (c) Multiple protein alignment with CCBE1 and its orthologs (reverse orientation). The affected amino acid is within the rectangle.
This cysteine is highly conserved amongst different organisms and the mutation is predicted to be deleterious to CCBE1 function
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this. It is possible that even the cognitive impairments
are secondary to in utero lymphatic abnormalities as this
is the least consistent feature of the syndrome and is
usually only present in the most severe cases. Theabnormal lymphatics could have a secondary effect on
neuronal development if they were severe enough during
the appropriate stage in gestation.
Our patient is likely the mildest to be reported with
mutations in CCBE1 to date. She has segmental gut
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Her development is unaffected, she has no dysmorphic
features and there is minimal acral lymphedema. She
had some in utero involvement given the nuchal thick-
ening of 6-7 mm noted prenatally but it clearly did not
have a large phenotypic consequence. This report ex-
tends the phenotype of Hennekam syndrome to include
even milder lymphatic dysplasias. We suggest that the
term Hennekam syndrome be used for a spectrum of
autosomal recessive lymphatic dysplasias that encompass
the “classic” form with more severe in utero effects
(hydrops fetalis, dysmorphism, cognitive impairment,
gut and other organ lymphangiectasia, severe lymph-
edema) to a milder form as presented here (gut lym-
phangiectasia, mild lymphedema). The presence of both
lymphangiectasias (particularly of the gut) and lymph-
edema would differentiate Hennekam syndrome from
other congenital primary lymphatic dysplasias like Mil-
roy syndrome (isolated acral lymphedema) and isolated
intestinal lymphangiectasia [14]. Our case highlights the
need for a very detailed clinical assessment in patients
with any suggestion of a lymphatic abnormality. Testing
should be directed by phenotype but CCBE1 sequencing
should be considered in even apparently isolated cases
of intestinal lymphangiectasia as the presence of lymph-
atic abnormalities outside of the gut may be subtle.
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